INVO Fertility

IVF · NASDAQ

$0.6016+$0.0006 (+0.10%)TodayMarket closed · Oct 20, 7:32 PM ET

Prev close $0.601

About IVF

INVO Fertility, Inc. operates as a revenue-generating fertility business. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.

Employees: 28
Headquarters: Sarasota, Florida
Listed: Nov 11, 2008
Sector: Health Care
Industry: Health Care Equipment & Supplies
Website: invofertility.com

Leadership

INVO Fertility executives
Name	Title	Since	Age
Steven Shum	—	2017	55
Terah Krigsvold	—	—	43
Andrea Goren	—	—	58
Daniel Teper	—	2024	64
Trent Davis	—	—	56
Rebecca Messina	—	—	52
Barbara Ryan	—	—	65
Matthew Szot	—	—	51
Robert Blum	—	2019	—

Similar companies

Companies in the same industry as INVO Fertility

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.